Interview: Alexander Willemse – CEO, BioConnection BV, The Netherlands
02.11.2015
Related Interviews
Peter DeYoung – CEO, Global Pharma, Piramal Pharma Limited
Peter DeYoung shares the significance of Indian giant Piramal Pharma’s recent demerger from its parent company and its current strategic focus on organic growth, brownfield expansions, and “complex hospital generics.”…
Sandeep Verma – Country Head, Consumer Health, Bayer India
Sandeep Verma shares his journey of establishing Bayer’s consumer healthcare division in India and reflects on the challenges faced during the division’s inception amidst the COVID-19 pandemic, emphasizing the importance…
Antonio Donato – CEO, Tecnimede Group
Last year, Tecnimede Group – a family-owned titan of the Portuguese healthcare industry – appointed its first professional, non-family CEO in Antonio Donato. This marked a significant milestone in the…
Brazil / Biophytis/Innovation Solutions Partnership; Eurofarma's Major Biotech Investment
The latest pharma news from Brazil, including the partnership between Biophytis and Innovation Solutions Pharma; Merck’s 100 years in Brazil; Eurofarma’s USD 100 million biotech investment, and GSK’s green light…
Algeria / Pharma & Healthcare: 5 Things to Know
With a healthcare system marked by both progress and difficulties due to the country’s economic overreliance on the oil and gas sector and its recent political instability, Algeria, is the…
Digital Transformation / 3 Insights from UCB CEO Jean-Christophe Tellier
UCB has been undergoing a far-reaching digital business transformation, integrating novel approaches across its R&D organisation, including Computer-Aided Drug Design (CADD) and AI, while striving to maintain a patient-centric focus.…
